Business solution
KLIFO Drug Development Counselling increases the value of development projects and operational strategies by bringing together a wide range of expertise across all key R&D functions to support our clients’ decision making. Based on thorough, data-driven assessments we help you to build robust drug development strategies.
Hanne Wulff Nielsen
Expertise &
therapy areas
Expertise
- Product development strategies and plans (overall, clinical, preclinical, CMC, regulatory)
- Documents for regulatory purposes (efficacy, safety, quality)
- Documents for planning and decision-making (project plans, TPPs, risk assessments, gap analyses, second opinions)
- Scientific advice/pre-IND (LoQ, briefing documents, facilitate meetings with authorities)
- Due diligence of projects and portfolios
- Interim experts (medical, clinical, preclinical, CMC, QA, biostatistics and regulatory)
- Interim project management, alliance management and R&D management.
- GCP Audits – site and CRO/Vendor audits. Support to optimizing your GCP Quality Management System.
- Medical writing
- Biostat
- Clinical CRO qualification, negotiation and oversight
At KLIFO Drug Development Counselling, we offer our services across a wide range of therapy areas including:
- Oncology
- Immunology
- Neurology
- Psychiatry
- Cardiology
- Diabetes
- Gastroenterology
- Respiratory Pain
- Infectious diseases
- Haematology